From the Archives -  Expert Perspectives

In honor of Breast Cancer Awareness Month, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and a member of the National Breast Cancer Foundation (NBCF) Medical Advisory Board discusses factors in the risk and prevention of breast cancer. Ms. Shockney shares advice for minimizing one's risk of developing breast cancer and explains the genetic factors that can come into play in the development of this disease.

Breast Cancer Risk Factors and Prevention With Lillie S. Shockney, RN, BS, MAS, HON-ONN-CG

In honor of Breast Cancer Awareness Month, Lillie Shockney RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and a member of the National Breast Cancer Foundation (NBCF) Medical Advisory Board, discusses the genetic factors that come into play in the development of breast cancer. In addition, she shares advice for which individuals should receive genetic testing and when, as well as strategies for counseling individuals who are undergoing genetic testing.

Breast Cancer Genetic Risk and Evaluation With Lillie S. Shockney, RN, BS, MAS, HON-ONN-CG

In honor of prostate cancer awareness month, Dr. Ulka Vaishampayan, will be discussing issues surrounding prostate cancer.

Perspectives on Metastatic and Castration-Resistant Prostate Cancer With Ulka Vaishampayan, MD

In her latest Breast Cancer Awareness Month video, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, discusses the importance of undergoing 3D mammography breast cancer screening, as well as the crucial role of breast imaging radiologists in this field.

Importance of 3D Mammogram Screening by Breast Imaging Radiologists With Lillie S. Shockney, RN

In this interview, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and medical advisory council member of the National Breast Cancer Foundation, discusses the pathology of breast cancer, prognostic factors for disease outcomes, and the crucial role of breast pathologists in setting the stage for diagnosis and treatment.

Breast Cancer Pathology and Setting the Stage for Treatment: Lillie Shockney, RN, HON-ONN-CG

In this interview in honor of Breast Cancer Awareness Month, Judy Herrick, RN, OCN®, ONN-CG, the Supervisor of Support Services at UT Southwestern Simmons Comprehensive Cancer Center, discusses the role of oncology nurse navigation and support services in ensuring that patients with breast cancer receive optimal care during their treatment. Ms. Herrick also discusses the importance of patient education and shares strategies for utilizing available resources to address all facets of breast cancer care.

Patients Need Layers of Support: Oncology Nurse Navigation With Judy Herrick, RN, OCN®, ONN-CG

In this interview, in honor of Breast Cancer Awareness Month, Tricia Trammell, BA, CRA, FAHRA, R.T. (R)(M)(QM)(BS), CN-BI, Breast Center Manager at UT Southwestern Simmons Comprehensive Cancer Center, discusses the advancements in breast imaging in relation to screening for breast cancer.

Developments in Breast Imaging and Radiology: A Conversation With Tricia Trammell

For this podcast in honor of Breast Cancer Awareness Month, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, discusses current standards and recent advances in breast cancer surgery, including lumpectomies, prophylactic mastectomies, and reconstructive procedures.

Understanding Breast Cancer Surgery and Reconstruction: Lillie S. Shockney, RN, BS, MAS, HON-ONN-CG

How can members of the cancer care team help their patients with breast cancer continue to thrive despite their diagnosis? Watch as Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, shares how to enhance quality of life preservation and restoration for breast cancer patients and survivors.

Enhancing Quality of Life  in Breast Cancer With Lillie Shockney, RN, BS, MAS

This podcast interview features Erin Prendergast, RN, CBCN®, an oncology nurse navigator and Senior Breast Clinical Coordinator in the Breast Cancer Program at UT Southwestern Simmons Comprehensive Cancer Center. Ms. Prendergast explains what she does in her role as an oncology nurse navigator and shares strategies that her team has implemented to ensure that patients with breast cancer receive optimal access to treatment and supportive care during the COVID-19 pandemic.

Overcoming Pandemic Challenges in Breast Cancer Care With Erin Prendergast, RN, CBCN®

Although the management of breast cancer has been impacted by the COVID-19 pandemic, the cancer care team has developed strategies to optimize screening and treatment experiences in spite of these challenges. In this podcast, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, shares advice advice regarding protocols for undergoing mammograms during the pandemic, including the timing of COVID-19 vaccination.

Breast Cancer and Pandemic Challenges With Lillie Shockney, RN, BS, MAS, HON-ONN-CG

How can members of the cancer care team enable breast cancer survivors to become breast cancer thrivers? Watch as Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation medical advisory council, explains how to provide optimal care and support for patients with breast cancer during their treatment and beyond.

How to Help Breast Cancer Survivors Become Breast Cancer Thrivers: Lillie Shockney, RN

In this recording of Oncology Data Advisor’s Live Breast Cancer Panel, three noted experts in breast cancer management partake in a conversation about recent advances in treatment, strategies and integrative medicine modalities to minimize toxicity, and techniques for enabling patients with breast cancer to thrive throughout their diagnosis and treatment.

Breast Cancer Awareness Month With Christine Samuel, Mikel Ross, and Lillie Shockney

For patients with breast cancer, the approach to treatment requires an individualized approach accounting for factors such as genetic risk, symptom management, and more recently, the challenges of the COVID-19 pandemic. In this interview, Dr. Valerie Brutus, a breast surgical oncologist at St. Vincent’s Medical Center of Hartford HealthCare, discusses strategies for successfully incorporating each of these factors into patients’ treatment.

Insights Into Breast Cancer Treatment and Management in the COVID-19 Pandemic: Valerie Brutus, MD

Significant progress has been made in numerous facets of breast cancer care in recent years, including developments in treatment, imaging, pathology, radiation, and surgery. In this interview, Dr. Richard Zelkowitz, a Regional Medical Director of the Breast Program at Hartford HealthCare, highlights the advances that have been made and explains the importance of subspecialties in ensuring that patients with breast cancer receive the most individualized care possible.

Making Strides in Breast Cancer Treatment With Richard Zelkowitz, MD

Over recent years, numerous developments have occurred in the fields of breast cancer prevention, genetic testing, screening, and surgical procedures. In this interview, Dr. Brigid Killelea, Medical Director of Breast Surgery at Hartford HealthCare, explains strategies for incorporating these advances into the care of patients with breast cancer.

Applying Recent Advances to Personalized Breast Cancer Care: Brigid Killelea, MD, FACS

Tumor suppressor gene p53 is the most frequently mutated gene in human malignancy. Through a complex series of molecular events, p53 leads to malignant cell proliferation and plays a significant role in tumor formation. In this interview with Oncology Data Advisor, Dr. Matthew Davids of Harvard Medical School delves further into the latest research in p53-directed therapeutic strategies and the future of targeting this specific mutation.

Targeting p53 in the Treatment of Hematologic Malignancies With Matthew Davids, MD, MMSc

In this interview, Dr. Thomas Abrams of Harvard Medical School discusses the role that cabozantinib/atezolizumab may play for patients with metastatic colorectal cancer, particularly those with RAS wild-type disease, in the coming years.

Cabozantinib/Atezolizumab for Metastatic Colorectal Cancer: Thomas Abrams, MD

Dr. Rahul Banerjee and Dr. Kelly Brassil discuss the design of an ongoing phase 2 trial investigating digital life coaching and its implications for improving the quality of life of patients undergoing ASCT for multiple myeloma.

Can Digital Life Coaching Improve Quality of Life in Transplant? Rahul Banerjee and Kelly Brassil

In honor of World Cancer Day, members of the Oncology Data Advisor (ODA) editorial board gathered to discuss the latest advances and future directions in oncology research. Dr. Thomas Abrams, an Assistant Professor of Medicine at Harvard Medical School shared recent progress in the field of gastrointestinal cancers; Dr. Ulka Vaishampayan, a Professor of Internal Medicine at the University of Michigan Rogel Cancer Center provided insights into current trends in genitourinary cancer research; and Beth Sandy, MSN, CRNP, an outpatient thoracic oncology nurse practitioner at the University of Pennsylvania Abramson Cancer Center, discussed recent and future treatment advances in the field of lung cancer.

World Cancer Day With Thomas Abrams, MD; Ulka Vaishampayan, MD; and Beth Sandy, MSN, CRNP

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

From the Archives - Expert Perspectives

Oncology Data Advisor®